Option Care Health to Participate in the J.P. Morgan Healthcare Conference
Rhea-AI Summary
Option Care Health (Nasdaq: OPCH) will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 with a presentation at 10:30am PT.
The company said the webcast and presentation materials will be available at https://investors.optioncarehealth.com. Option Care Health describes itself as the nation’s largest independent provider of home and alternate site infusion services, with over 8,000 team members including more than 5,000 clinicians serving all 50 states.
Positive
- None.
Negative
- None.
News Market Reaction – OPCH
In the Dec 12 session, OPCH gained 1.03%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Nov 03 | Investor conferences | Neutral | +1.5% | Announced participation in four investor conferences with webcast access for updates. |
| Oct 30 | Q3 2025 earnings | Positive | -8.6% | Reported Q3 2025 revenue and adjusted EPS growth with updated full-year guidance. |
| Sep 25 | Earnings scheduling | Neutral | +1.8% | Set date and time for Q3 2025 results release and conference call details. |
| Aug 25 | Investor conferences | Neutral | -0.5% | Outlined participation in two September healthcare conferences and nationwide operations. |
| Aug 20 | CFO transition | Neutral | -4.7% | Announced appointment of new CFO and advisor role for outgoing CFO during transition. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings news previously saw a notable negative reaction despite growth metrics, while routine conference and scheduling updates have tended to see modest, generally aligned price moves.
Over the last few months, Option Care Health has combined steady investor engagement with financial and leadership developments. The company reported Q3 2025 results on Oct 30, showing revenue and EBITDA growth but a -8.6% price reaction. Multiple conference-participation announcements on Aug 25 and Nov 03 framed ongoing outreach to investors, with modest price moves. A CFO transition disclosed on Aug 20 prompted a -4.66% reaction. Today’s J.P. Morgan conference participation fits the recurring theme of conference updates rather than a new financial catalyst.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BANNOCKBURN, Ill., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the 44th Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Tuesday, January 13, 2026, including a presentation at 10:30am PT. The webcast and related presentation materials will be available online at https://investors.optioncarehealth.com.
About Option Care Health
Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 8,000 team members including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at optioncarehealth.com.
For Investor Inquiries:
| Stephen Shulstein |
| Vice President, Investor Relations |
| stephen.shulstein@optioncare.com |
